Company Filing History:
Years Active: 2017-2022
Title: Innovations of Geetika Phukan: Pioneering Biomarkers for Nanoparticle Toxicity
Introduction: Geetika Phukan is an accomplished inventor based in Suwon-si, South Korea. With an impressive portfolio of two patents, her work is at the forefront of research in neurotoxicity and nanoparticle assessment. Her innovative approaches have the potential to significantly impact the field of health and safety regarding nanoparticle exposures.
Latest Patents: Phukan's contributions include groundbreaking patents focused on diagnosing neurotoxicity. Her latest patents encompass a bio-marker composition designed to assess the neurotoxicity of nanoparticles. This methodology involves preparing a tissue or cell sample from mammals that have been exposed to nanoparticles. It then analyzes specific polyamine metabolites and compares their expression levels with those of a control sample.
Another notable patent she holds is related to a biomarker for diagnosing the toxicity of nanoparticles. This innovation comprises a gene marker with high correlation to nanoparticle toxicity, allowing for accurate identification and assessment. The method offers a novel approach for evaluating the toxicity of nanoparticles, aiding in health monitoring and disease research linked to nanoparticle exposure.
Career Highlights: Geetika Phukan's career is highlighted by her association with the Ajou University Industry-Academic Cooperation Foundation. Here, she applies her extensive knowledge and skills toward enhancing understanding of nanoparticle interactions within biological systems, contributing to both academic and practical advancements in the field.
Collaborations: Throughout her career, Phukan has collaborated with experts in her field, such as Gwang Hwan Lee and Man Jeong Paik. These collaborations reflect her commitment to advancing research in health sciences, particularly concerning the implications of nanoparticle exposure.
Conclusion: Geetika Phukan's innovative work in the development of biomarkers for evaluating nanoparticle toxicity showcases her significant contributions to science and medicine. Her patents represent a step forward in understanding the health risks associated with nanoparticles, emphasizing the importance of her ongoing research and collaboration in this vital area.